Cellectar Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLEICHROEDER LP | 02/13/2026 | 100.00 K | $295.00 K | 0.00% | 3.83% |
| VANGUARD GROUP INC | 01/29/2026 | 89.12 K | $262.90 K | 36.75% | 3.42% |
| DRW SECURITIES, LLC | 02/12/2026 | 45.19 K | $133.31 K | 114.16% | 1.73% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 28.64 K | $84.48 K | 15.04% | 1.10% |
| SEQUOIA FINANCIAL ADVISORS, LLC | 02/03/2026 | 25.35 K | $74.78 K | 135.09% | 0.97% |
| WARBERG ASSET MANAGEMENT LLC | 02/13/2026 | 13.90 K | $41.01 K | 100.00% | 0.53% |
| XTX TOPCO LTD | 02/17/2026 | 12.24 K | $36.12 K | 100.00% | 0.47% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 12.20 K | $36.00 K | 100.00% | 0.47% |
| RIVERVIEW CAPITAL ADVISERS, LLC | 02/17/2026 | 10.38 K | $50.05 K | 0.00% | 0.40% |
| BLACKROCK, INC. | 02/12/2026 | 4.75 K | $14.00 K | 0.00% | 0.18% |
| UBS GROUP AG | 01/29/2026 | 2.60 K | $7.66 K | 186.12% | 0.10% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1.83 K | $5.41 K | 68.17% | 0.07% |
| MORGAN STANLEY | 02/13/2026 | 510 | $1.51 K | 0.00% | 0.02% |
| TD WATERHOUSE CANADA INC. | 01/27/2026 | 63 | $181 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 36 | $106 | 33.33% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 11 | $32 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 7 | $19 | -69.57% | 0.00% |
| US BANCORP \DE\ | 01/30/2026 | 3 | $9 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 02/17/2026 | 3 | $9 | 0.00% | 0.00% |
| DANSKE BANK A/S | 02/02/2026 | 2 | $6 | 0.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cellectar Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 40 institutional investors and hedge funds held shares of Cellectar Biosciences Inc. The most heavily invested institutionals were:
Sequoia Financial Advisors, LLC: 18,850
VANGUARD FIDUCIARY TRUST CO: 16,573
Warberg Asset Management LLC: 13,900
UBS Group AG: 9,647
Vanguard Global Advisers, LLC: 563
TD Waterhouse Canada Inc.: 63
13.30% of Cellectar Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 3.06 M shares in the last 24 months. This purchase volume represents approximately $8.41 M in transactions.